Quick answers
- What is Junel 21 Day?
- Junel 21 Day is a brand name of Norethindrone acetate and ethinyl estradiol, a prescription medicine. The FDA NDC Directory lists 3 Junel 21 Day products in 2 strengths and forms.
- Who makes Junel 21 Day?
- Barr Labs holds the FDA application for Junel 21 Day (ANDA076380, approved May 30, 2003). 1 other company (repackagers or distributors) also list Junel 21 Day products.
- Is there a generic or store brand of Junel 21 Day?
- Yes. The FDA NDC Directory lists 6 other products with the same active ingredients, strength and form as a Junel 21 Day product, 6 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Junel 21 Day?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 2 Junel 21 Day strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Junel 21 Day been recalled?
- FDA enforcement reports list 1 recall of Junel 21 Day products; the newest started March 15, 2013. A recall usually concerns specific lots, not every product.
What Junel 21 Day is
Each Junel 21 Day product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Norethindrone acetate and ethinyl estradiol · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| ethinyl estradiol 20 ug · norethindrone acetate 1 mg tablet (oral) | Junel 21 Day | 3 products, 3 companies | DailyMed |
| ethinyl estradiol 30 ug · norethindrone acetate 1.5 mg tablet (oral) | Junel 21 Day | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Norethindrone acetate and ethinyl estradiol →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA076380 | Barr Labs | May 30, 2003 | 2 |
| ANDA076381 | Barr | May 30, 2003 | 1 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| ethinyl estradiol 20 ug · norethindrone acetate 1 mg tablet | Generic: Junel 21 Day | $0.1760 per tablet Generic of the same strength and form: $0.1760 per tablet |
| ethinyl estradiol 30 ug · norethindrone acetate 1.5 mg tablet | Generic: Junel 21 Day | $0.3169 per tablet Generic of the same strength and form: $0.3169 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Junel 21 Day
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Junel 21 Day products.
- Teva Pharmaceuticals USA, Inc.2 products
- Proficient Rx LP1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 15, 2013 · Class III · Terminated · D-682-2013
Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing
Junel(TM) Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), 28 day regimen, Rx only, Barr laboratories, Pomona, NY --- NDC 0555-9028-58 — Teva Pharmaceuticals USA, Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.